Adjunctive Hyperbaric Oxygen Therapy in Refractory Crohn's Disease: An Observational Study
- PMID: 33995526
- PMCID: PMC8096584
- DOI: 10.1155/2021/6628142
Adjunctive Hyperbaric Oxygen Therapy in Refractory Crohn's Disease: An Observational Study
Abstract
Background and aims: Patients may experience complications of Crohn's disease (CD) even when treated with optimal medical therapy strategies. Previous data have shown the efficacy of hyperbaric oxygen therapy (HBOT) in the management of complicated CD. However, there is no consensus regarding the optimal number of sessions or duration of treatment regimens. The aim of the present study was to investigate the efficacy of HBOT in CD patients who were refractory to conventional medical management.
Methods: This study included patients who underwent HBOT for the treatment of the following complications: perianal fistulizing Crohn's disease (pCD), enterocutaneous fistulas (ECF), or pyoderma gangrenosum (PG). Complete healing was defined as the closure of external orifice and the absence of active draining (in pCD), complete wound healing (in PG), and granulation or complete wound epithelialization with no enteric draining (in ECF). The persistence of draining and the absence of wound granulation were defined as incomplete healing.
Results: Forty patients were included. The mean CD duration was 10.6 ± 5.8 years. pCD comprised most of the included patients (25/62.5%), followed by ECF (n = 13/32.5%) and PG (n = 6/15%). In two patients (5%), a combination of ECF and PG was diagnosed, and in one patient (2.5%), all three complications were observed. A total of 32 patients (82.5%) had complete healing. Patients with PG had the highest healing rates (100%), followed by those with ECF (84.6%) and pCD (80%).
Conclusions: Adjunctive HBO was associated with significant healing rates for CD-associated complications such as pCD, ECF, and PG.
Copyright © 2021 Marley R. Feitosa et al.
Conflict of interest statement
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures



Similar articles
-
Hyperbaric Oxygen Therapy Achieved Fistula Healing in a Young Patient With Severe Refractory Perianal Crohn's Disease.Cureus. 2024 Jun 23;16(6):e62987. doi: 10.7759/cureus.62987. eCollection 2024 Jun. Cureus. 2024. PMID: 39050284 Free PMC article.
-
Adjunctive Hyperbaric Oxygen Therapy promotes successful healing in patients with refractory Crohn's disease.Acta Cir Bras. 2016;31 Suppl 1:19-23. doi: 10.1590/S0102-86502016001300005. Acta Cir Bras. 2016. PMID: 27142900
-
Intraoperative Autologous Platelet-Rich Stroma Injection as Add-On to Fistula Curettage and Closure of the Internal Orifice Demonstrates a Favorable Outcome in Long-Term in Patients Suffering from Therapy-Refractory Perianal Fistulizing Crohn's Disease.Inflamm Bowel Dis. 2025 May 24:izaf011. doi: 10.1093/ibd/izaf011. Online ahead of print. Inflamm Bowel Dis. 2025. PMID: 40411444
-
Efficacy of ustekinumab for active perianal fistulizing Crohn's disease: a systematic review and meta-analysis of the current literature.Scand J Gastroenterol. 2021 Jan;56(1):53-58. doi: 10.1080/00365521.2020.1854848. Epub 2020 Dec 2. Scand J Gastroenterol. 2021. PMID: 33264569
-
Medical Therapy of Perianal Crohn's Disease.Viszeralmedizin. 2015 Aug;31(4):265-72. doi: 10.1159/000434664. Epub 2015 Jul 29. Viszeralmedizin. 2015. PMID: 26557835 Free PMC article. Review.
Cited by
-
The new insights of hyperbaric oxygen therapy: focus on inflammatory bowel disease.Precis Clin Med. 2024 Jan 18;7(1):pbae001. doi: 10.1093/pcmedi/pbae001. eCollection 2024 Mar. Precis Clin Med. 2024. PMID: 38344218 Free PMC article. Review.
-
Hyperbaric Oxygen Therapy in the Treatment of Crohn's Disease.Healthcare (Basel). 2025 Jan 11;13(2):128. doi: 10.3390/healthcare13020128. Healthcare (Basel). 2025. PMID: 39857155 Free PMC article.
-
Use of vedolizumab combined with hyperbaric oxygen therapy to treat enteric fistula in Crohn's disease.Med Gas Res. 2024 Sep 1;14(3):133-135. doi: 10.4103/2045-9912.385948. Epub 2024 Mar 20. Med Gas Res. 2024. PMID: 40232689 Free PMC article. No abstract available.
-
Hyperbaric Oxygen Therapy Achieved Fistula Healing in a Young Patient With Severe Refractory Perianal Crohn's Disease.Cureus. 2024 Jun 23;16(6):e62987. doi: 10.7759/cureus.62987. eCollection 2024 Jun. Cureus. 2024. PMID: 39050284 Free PMC article.
-
A Review of Hyperbaric Oxygen Therapy for Inflammatory Bowel Disease.Int J Gen Med. 2021 Oct 24;14:7099-7105. doi: 10.2147/IJGM.S336678. eCollection 2021. Int J Gen Med. 2021. PMID: 34729019 Free PMC article. Review.
References
-
- Schwartz D. A., Tagarro I., Carmen Diez M., Sandborn W. J. Prevalence of fistulizing Crohn’s disease in the United States: estimate from a systematic literature review attempt and population-based database analysis. Inflammatory Bowel Diseases. 2019;25(11):1773–1779. doi: 10.1093/ibd/izz056. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources